236 related articles for article (PubMed ID: 34421363)
21. Expression and Functions of Formyl Peptide Receptor 1 in Drug-Resistant Bladder Cancer.
Jiang X; Lei T; Zhang M
Technol Cancer Res Treat; 2018 Jan; 17():1533034618769413. PubMed ID: 29665744
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of sensitivity of urinary bladder tumor cells to cisplatin by c-myc antisense oligonucleotide.
Mizutani Y; Fukumoto M; Bonavida B; Yoshida O
Cancer; 1994 Nov; 74(9):2546-54. PubMed ID: 7923012
[TBL] [Abstract][Full Text] [Related]
23. Human urinary bladder cancer T24 cells are susceptible to the Antrodia camphorata extracts.
Peng CC; Chen KC; Peng RY; Su CH; Hsieh-Li HM
Cancer Lett; 2006 Nov; 243(1):109-19. PubMed ID: 16455193
[TBL] [Abstract][Full Text] [Related]
24. HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition.
Selvendiran K; Ahmed S; Dayton A; Kuppusamy ML; Rivera BK; Kálai T; Hideg K; Kuppusamy P
Cancer Biol Ther; 2011 Nov; 12(9):837-45. PubMed ID: 21885917
[TBL] [Abstract][Full Text] [Related]
25. Long noncoding RNA GAS5 inhibits malignant proliferation and chemotherapy resistance to doxorubicin in bladder transitional cell carcinoma.
Zhang H; Guo Y; Song Y; Shang C
Cancer Chemother Pharmacol; 2017 Jan; 79(1):49-55. PubMed ID: 27878359
[TBL] [Abstract][Full Text] [Related]
26. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y
Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046
[TBL] [Abstract][Full Text] [Related]
27. CDK7 inhibition by THZ1 suppresses cancer stemness in both chemonaïve and chemoresistant urothelial carcinoma via the hedgehog signaling pathway.
Chow PM; Chang YW; Kuo KL; Lin WC; Liu SH; Huang KH
Cancer Lett; 2021 Jun; 507():70-79. PubMed ID: 33741425
[TBL] [Abstract][Full Text] [Related]
28. Targeting HNRNPU to overcome cisplatin resistance in bladder cancer.
Shi ZD; Hao L; Han XX; Wu ZX; Pang K; Dong Y; Qin JX; Wang GY; Zhang XM; Xia T; Liang Q; Zhao Y; Li R; Zhang SQ; Zhang JH; Chen JG; Wang GC; Chen ZS; Han CH
Mol Cancer; 2022 Feb; 21(1):37. PubMed ID: 35130920
[TBL] [Abstract][Full Text] [Related]
29. Sunitinib can enhance BCG mediated cytotoxicity to transitional cell carcinoma through apoptosis pathway.
Ping SY; Wu CL; Yu DS
Urol Oncol; 2012 Sep; 30(5):652-9. PubMed ID: 20884251
[TBL] [Abstract][Full Text] [Related]
30. Enhanced sensitivity of bladder cancer cells to cisplatin mediated cytotoxicity and apoptosis in vitro and in vivo by the selective cyclooxygenase-2 inhibitor JTE-522.
Mizutani Y; Nakanishi H; Li YN; Sato N; Kawauchi A; Miki T
J Urol; 2004 Oct; 172(4 Pt 1):1474-9. PubMed ID: 15371874
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of G9a by a small molecule inhibitor, UNC0642, induces apoptosis of human bladder cancer cells.
Cao YP; Sun JY; Li MQ; Dong Y; Zhang YH; Yan J; Huang RM; Yan X
Acta Pharmacol Sin; 2019 Aug; 40(8):1076-1084. PubMed ID: 30765842
[TBL] [Abstract][Full Text] [Related]
32. Targeting urothelial carcinoma cells by combining cisplatin with a specific inhibitor of the autophagy-inducing class III PtdIns3K complex.
Schlütermann D; Skowron MA; Berleth N; Böhler P; Deitersen J; Stuhldreier F; Wallot-Hieke N; Wu W; Peter C; Hoffmann MJ; Niegisch G; Stork B
Urol Oncol; 2018 Apr; 36(4):160.e1-160.e13. PubMed ID: 29276062
[TBL] [Abstract][Full Text] [Related]
33. Doxorubicin treatment modulates chemoresistance and affects the cell cycle in two canine mammary tumour cell lines.
Levi M; Salaroli R; Parenti F; De Maria R; Zannoni A; Bernardini C; Gola C; Brocco A; Marangio A; Benazzi C; Muscatello LV; Brunetti B; Forni M; Sarli G
BMC Vet Res; 2021 Jan; 17(1):30. PubMed ID: 33461558
[TBL] [Abstract][Full Text] [Related]
34. PR-619, a General Inhibitor of Deubiquitylating Enzymes, Diminishes Cisplatin Resistance in Urothelial Carcinoma Cells through the Suppression of c-Myc: An In Vitro and In Vivo Study.
Hsu FS; Lin WC; Kuo KL; Chiu YL; Hsu CH; Liao SM; Dong JR; Liu SH; Chang SC; Yang SP; Chen YT; Chang RJ; Huang KH
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769137
[TBL] [Abstract][Full Text] [Related]
35. Bufalin induces G0/G1 phase arrest through inhibiting the levels of cyclin D, cyclin E, CDK2 and CDK4, and triggers apoptosis via mitochondrial signaling pathway in T24 human bladder cancer cells.
Huang WW; Yang JS; Pai SJ; Wu PP; Chang SJ; Chueh FS; Fan MJ; Chiou SM; Kuo HM; Yeh CC; Chen PY; Tsuzuki M; Chung JG
Mutat Res; 2012 Apr; 732(1-2):26-33. PubMed ID: 22285700
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of Long Non-Coding RNA XIST Inhibited Doxorubicin Resistance in Colorectal Cancer by Upregulation of miR-124 and Downregulation of SGK1.
Zhu J; Zhang R; Yang D; Li J; Yan X; Jin K; Li W; Liu X; Zhao J; Shang W; Yu T
Cell Physiol Biochem; 2018; 51(1):113-128. PubMed ID: 30439718
[TBL] [Abstract][Full Text] [Related]
37. Metformin can block precancerous progression to invasive tumors of bladder through inhibiting STAT3-mediated signaling pathways.
Pan Q; Yang GL; Yang JH; Lin SL; Liu N; Liu SS; Liu MY; Zhang LH; Huang YR; Shen RL; Liu Q; Gao JX; Bo JJ
J Exp Clin Cancer Res; 2015 Aug; 34(1):77. PubMed ID: 26245871
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of Stat3 activity by YC-1 enhances chemo-sensitivity in hepatocellular carcinoma.
Lau CK; Yang ZF; Lam SP; Lam CT; Ngai P; Tam KH; Poon RT; Fan ST
Cancer Biol Ther; 2007 Dec; 6(12):1900-7. PubMed ID: 18059167
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of the EGFR/STAT3/CEBPD Axis Reverses Cisplatin Cross-resistance with Paclitaxel in the Urothelial Carcinoma of the Urinary Bladder.
Wang WJ; Li CF; Chu YY; Wang YH; Hour TC; Yen CJ; Chang WC; Wang JM
Clin Cancer Res; 2017 Jan; 23(2):503-513. PubMed ID: 27435393
[TBL] [Abstract][Full Text] [Related]
40. Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1/2.
Park BH; Lim JE; Jeon HG; Seo SI; Lee HM; Choi HY; Jeon SS; Jeong BC
Oncotarget; 2016 Sep; 7(39):63870-63886. PubMed ID: 27564099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
